Cure My Disease

Don't miss your cure!

 Log in / Sign up

AR goggles could help surgeons spot cancer cells left behind during breast cancer surgery

NCT ID NCT07696754

Not yet recruiting Disease control Sponsor: Ss. Cyril and Methodius University of Skopje Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial tests whether special augmented-reality goggles can help surgeons find lymph nodes that may be missed during breast cancer surgery. The goggles show a fluorescent dye that collects in lymph nodes, allowing the surgeon to re-examine the area after the planned removal is complete. Thirty patients having breast cancer surgery with lymph node removal will take part. The study measures how often this technique finds cancer-containing nodes that would otherwise have remained, which could improve cancer staging and treatment planning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Augmented-reality goggles with indocyanine green dye
What this could lead to
If successful, this approach could help surgeons remove more cancer-containing lymph nodes during breast cancer surgery, leading to more accurate staging and potentially better outcomes.
What could go wrong
This is a small early-stage study with only 30 participants. The goggles may not find additional nodes in many cases, and removing extra tissue could carry surgical risks. Results need confirmation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Lymphatic Metastasis metastatic malignant neoplasm in the lymph nodes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST NEOPLASMS LYMPHATIC METASTASIS SENTINEL LYMPH NODE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Clinic for Thoracic and Vascular Surgery, Faculty of Medicine, UKIM

    Skopje, 1000, North Macedonia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.